Benzinga | Jul 23, 2020 04:15PM EDT

Edwards Lifesciences Q2 Adj. EPS $0.34 Beats $0.17 Estimate, Sales $925.00M Beat $789.42M Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.17 by 100 percent. This is a 75.36 percent decrease over earnings of $1.38 per share from the same period last year. The company reported quarterly sales of $925.00 million which beat the analyst consensus estimate of $789.42 million by 17.17 percent. This is a 14.90 percent decrease over sales of $1.09 billion the same period last year.